Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 509
Filtrar
1.
J Behav Health Serv Res ; 51(1): 123-131, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37872261

RESUMEN

Technology transfer centers (TTCs) facilitate the movement of evidence-based practices in behavioral healthcare from theory to practice. One of the largest such networks is the Substance Abuse and Mental Health Services Administration's (SAMHSA) TTC Network. This brief report shares findings from an organizational network analysis (ONA) of the network conducted as part of an external evaluation. For non-supervisory TTCs (n = 36) across three focus areas (addiction, prevention, and mental health), the authors computed network density, harmonic closeness, and non-null dyadic reciprocity for five types of interactions (e.g., "collaborated in workgroups"), then, for each interaction type, used Welch's T-test to compare mean harmonic closeness of standalone TTC grantees versus multiple-TTC grantees. ONA identified potentially isolated regional TTCs as well as mismatches between some centers' desired scope and their network centrality and enabled investigation of broader questions around behavioral health support systems. The approach appears useful for evaluating TTCs and similar support networks.


Asunto(s)
Conducta Adictiva , Servicios de Salud Mental , Trastornos Relacionados con Sustancias , Estados Unidos , Humanos , United States Substance Abuse and Mental Health Services Administration , Transferencia de Tecnología , Trastornos Relacionados con Sustancias/prevención & control
2.
J Behav Health Serv Res ; 51(2): 302-308, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37921952

RESUMEN

Data collection is an integral part of government agencies like the Substance Abuse and Mental Health Administration (SAMHSA), for reporting program outcomes and accountability. SAMHSA-funded community behavioral health programs have been evaluated by the National Outcome Measures (NOMs) since 2007. NOMs collects data on important aspects of client health including but not limited to mental health symptoms, functioning, and social connectedness through interviews with clients. Since its inception, NOMs has gone through a number of revisions. The most recent revision in 2021 has significant implications for program evaluation and research. This commentary provides an overview of the history of the NOMs followed by a review and critique of the recent changes with a particular attention to revisions in how responses are recorded. Implications of the NOMs are discussed with respect to its utility in evaluation, practice, and research.


Asunto(s)
Trastornos Relacionados con Sustancias , United States Substance Abuse and Mental Health Services Administration , Estados Unidos , Humanos , Trastornos Relacionados con Sustancias/terapia , Salud Mental , Evaluación de Resultado en la Atención de Salud , Evaluación de Programas y Proyectos de Salud/métodos
5.
Subst Abus ; 42(2): 148-152, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33849399

RESUMEN

The novel coronavirus has thrown large sections of our healthcare system into disarray, with providers overburdened by record breaking number of hospitalizations and deaths. The U.S., in particular, has remained the nation with one of the fastest growing case counts in the world. As a consequence, many other critical healthcare needs have not received the necessary resources or consideration. This commentary draws attention to substance use and opioid access during the ongoing crisis, given the potential for breakdowns in treatment access for addiction, the growing concern of mental health comorbidities, and the lack of access for those who require opioids for adequate pain management. Further, the commentary will offer policy and practice recommendations that may be implemented to provide more equitable distribution of care.


Asunto(s)
Analgésicos Opioides/uso terapéutico , COVID-19 , Accesibilidad a los Servicios de Salud , Trastornos Relacionados con Opioides/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Política Pública , Alcoholismo , Buprenorfina/uso terapéutico , Registros Electrónicos de Salud , Reducción del Daño , Humanos , Internet de las Cosas , Sobredosis de Opiáceos/prevención & control , Tratamiento de Sustitución de Opiáceos/métodos , Epidemia de Opioides , Manejo del Dolor , Cuidados Paliativos , Sistemas de Apoyo Psicosocial , SARS-CoV-2 , Telemedicina , Estados Unidos , United States Substance Abuse and Mental Health Services Administration
6.
Pediatrics ; 147(Suppl 2): S220-S228, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33386325

RESUMEN

In summarizing the proceedings of a longitudinal meeting of experts in substance use disorders (SUDs) among young adults, this special article reviews principles of care concerning recovery support services for this population. Young adults in recovery from SUDs can benefit from a variety of support services throughout the process of recovery. These services take place in both traditional clinical settings and settings outside the health system, and they can be delivered by a wide variety of nonprofessional and paraprofessional individuals. In this article, we communicate fundamental points related to guidance, evidence, and clinical considerations about 3 basic principles for recovery support services: (1) given their developmental needs, young adults affected by SUDs should have access to a wide variety of recovery support services regardless of the levels of care they need, which could range from early intervention services to medically managed intensive inpatient services; (2) the workforce for addiction services for young adults benefits from the inclusion of individuals with lived experience in addiction; and (3) recovery support services should be integrated to promote recovery most effectively and provide the strongest possible social support.


Asunto(s)
Prestación Integrada de Atención de Salud , Accesibilidad a los Servicios de Salud , Grupo de Atención al Paciente/organización & administración , Sistemas de Apoyo Psicosocial , Trastornos Relacionados con Sustancias/terapia , Actividades Cotidianas , Conferencias de Consenso como Asunto , Episodio de Atención , Medicina Basada en la Evidencia , Recursos en Salud , Vivienda , Humanos , Relaciones Interpersonales , Recuperación de la Salud Mental , Estados Unidos , United States Substance Abuse and Mental Health Services Administration , Adulto Joven
7.
PLoS One ; 16(1): e0245920, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33507985

RESUMEN

Between January 2016 and June 2020, the Substance Abuse and Mental Health Services Administration rapidly distributed $7.5 billion in response to the U.S. opioid crisis. These funds are designed to increase access to medications for addiction treatment, reduce unmet treatment need, reduce overdose death rates, and provide and sustain effective prevention, treatment and recovery activities. It is unclear whether or not the services developed using these funds will be sustained beyond the start-up period. Based on 34 (64%) State Opioid Response (SOR) applications, we assessed the states' sustainability plans focusing on potential funding sources, policies, and quality monitoring. We found variable commitment to sustainability across response plans with less than half the states adequately describing sustainability plans. States with higher proportions of opioid prescribing, opioid misuse, and poverty had somewhat higher scores on sustainment. A text mining/machine learning approach automatically rated sustainability in SOR applications with an 82% accuracy compared to human ratings. Because life saving evidence-based programs and services may be lost, intentional commitment to sustainment beyond the bolus of start-up funding is essential.


Asunto(s)
Minería de Datos , Servicios de Salud Mental/organización & administración , Epidemia de Opioides , Políticas , Analgésicos Opioides/uso terapéutico , Sobredosis de Droga/tratamiento farmacológico , Humanos , Trastornos Relacionados con Opioides/tratamiento farmacológico , Estados Unidos , United States Substance Abuse and Mental Health Services Administration
8.
Subst Abuse Treat Prev Policy ; 15(1): 85, 2020 11 11.
Artículo en Inglés | MEDLINE | ID: mdl-33176839

RESUMEN

BACKGROUND: Measuring behavioral health treatment accessibility requires timely, comprehensive and accurate data collection. Existing public sources of data have inconsistent metrics, delayed times to publication and do not measure all factors related to accessibility. This study seeks to capture this additional information and determine its importance for informing accessibility and care coordination. METHODS: The 2018 National Survey for Substance Abuse and Treatment Services (N-SSATS) data were used to identify behavioral health facilities in Indiana and gather baseline information. A telephone survey was administered to facilities with questions parallel to the N-SSATS and additional questions regarding capacity and patient intake. Quantitative analysis includes chi-square tests. A standard qualitative analysis was used for theming answers to open-ended questions. RESULTS: About 20% of behavioral health facilities responded to the study survey, and non-response bias was identified by geographic region. Among respondents, statistically significant differences were found in several questions asked in both the study survey and N-SSATS. Data gathered from the additional questions revealed many facilities to have wait times to intake longer than 2 weeks, inconsistency in intake assessment tools used, limited capacity for walk-ins and numerous requirements for engaging in treatment. CONCLUSION: Despite the low response rate to this study survey, results demonstrate that multiple factors not currently captured in public data sources can influence coordination of care. The questions included in this study survey could serve as a framework for routinely gathering these data and can facilitate efforts for successful coordination of care and clinical decision-making.


Asunto(s)
Servicios de Salud Mental/organización & administración , Sector Público/organización & administración , Centros de Tratamiento de Abuso de Sustancias/organización & administración , Accesibilidad a los Servicios de Salud/organización & administración , Humanos , Sector Público/normas , Estados Unidos , United States Substance Abuse and Mental Health Services Administration
9.
Subst Abuse Treat Prev Policy ; 15(1): 76, 2020 10 08.
Artículo en Inglés | MEDLINE | ID: mdl-33032639

RESUMEN

BACKGROUND: Despite conflicting results in the literature concerning its efficacy in practice, racial matching has been identified as a component of culturally sensitive treatment. METHODS: This study examined the perceived importance and prevalence of racial matching by surveying a national sample of substance use disorder (SUD) centers from the Substance Abuse and Mental Health Services Administration (SAMHSA). RESULTS: Using univariate statistical analysis, results for the prevalence of racial matching revealed that in 58% of the clinics, there was the potential to match a counselor with a racially similar client, while in 39% of the clinics, there was no potential to provide such a match. Among the agencies that displayed a potential for racial matching, 26% of the respondents indicated that they never racially matched clients and therapists, 71% reported that they sometimes practice racial matching, 15% indicated that they usually racially match, and only 7% purported to always racially match clients and therapists. Results for the perceived importance of racial matching revealed that in both situations where treatment centers had the potential for racial matching and did not have the potential for racial matching, supervisors reported that it was relatively important to provide culturally sensitive treatment but that it was not as important to match clients in SUD centers with racially/ethnically similar counselors. CONCLUSION: The topic of racial matching can be very complex and has shown variation amongst SUD centers; however, this study emphasizes the importance of providing culturally sensitive treatment and an appreciation of differences among members within each racial group.


Asunto(s)
Conducta Adictiva/terapia , Etnicidad , Grupos Raciales , Centros de Tratamiento de Abuso de Sustancias/organización & administración , Centros de Tratamiento de Abuso de Sustancias/estadística & datos numéricos , Competencia Cultural , Femenino , Humanos , Masculino , Prevalencia , Estados Unidos , United States Substance Abuse and Mental Health Services Administration
10.
Drug Alcohol Depend ; 217: 108329, 2020 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-33075691

RESUMEN

The United States is facing two devastating public health crises- the opioid epidemic and the COVID-19 pandemic. Within this context, one of the most ambitious implementation studies in addiction research is moving forward. Launched in May 2019, the HEALing Communities Study (HCS) was developed by the National Institutes of Health (NIH) and the Substance Abuse and Mental Health Services Administration (SAMHSA) as part of the Helping to End Addiction Long-termSM Initiative (National Institutes of Health, 2020). The goal for this research was to reduce opioid overdose deaths by 40 % in three years by enhancing and integrating the delivery of multiple evidence-based practices (EBPs) with proven effectiveness in reducing opioid overdose deaths across health care, justice, and community settings. This paper describes the initial vision, goals, and objectives of this initiative; the impact of COVID-19; and the potential for knowledge to be generated from HCS at the intersection of an unrelenting epidemic of opioid misuse and overdoses and the ravishing COVID-19 pandemic.


Asunto(s)
Analgésicos Opioides/efectos adversos , COVID-19/epidemiología , Práctica Clínica Basada en la Evidencia/métodos , Sobredosis de Opiáceos/mortalidad , Salud Pública/métodos , Analgésicos Opioides/uso terapéutico , COVID-19/prevención & control , Práctica Clínica Basada en la Evidencia/tendencias , Humanos , Sobredosis de Opiáceos/diagnóstico , Sobredosis de Opiáceos/prevención & control , Trastornos Relacionados con Opioides/diagnóstico , Trastornos Relacionados con Opioides/tratamiento farmacológico , Trastornos Relacionados con Opioides/mortalidad , Pandemias , Salud Pública/tendencias , Estados Unidos/epidemiología , United States Substance Abuse and Mental Health Services Administration/tendencias
11.
Implement Sci ; 15(1): 71, 2020 09 03.
Artículo en Inglés | MEDLINE | ID: mdl-32883352

RESUMEN

BACKGROUND: Enhancing the sustainability of evidence-based prevention programs for mental and behavioral health requires tools for measuring both sustainability determinants and sustainment outcomes. The aim of this study was to develop the Sustainment Measurement System Scale (SMSS) and to assess its reliability and construct validity for measuring both determinants and outcomes of efforts to sustain prevention programs and initiatives. METHODS: A 42-item scale comprised of items identified from qualitative data collected from 45 representatives of 10 programs and 8 SAMHSA program officers was administered to 186 representatives of 145 programs funded by 7 SAMHSA prevention grant initiatives. Cronbach's alphas were used to determine inter-item reliability. Convergent validity was assessed by comparisons of a global measure of sustainment with current SAMHSA-funding status and continued operation in the same form. Discriminant validity was assessed by comparisons of sustainability determinants with whether or not the program had undergone adaptations. RESULTS: Confirmatory factor analysis provided support for a 35-item model fit to the data. Cronbach's alpha was .84 for the sustainment outcome construct and ranged from .70 to .93 for the sustainability determinant constructs. All of the determinant constructs were significantly associated with sustainment outcome individual and global measures for the entire sample (p < 0.01 to 0.001) and for community-based programs and programs with a substance abuse focus (p < 0.05 to 0.001). Convergent validity was supported by significant associations between the global sustainment measure and current SAMHSA funding status and continued operation in the same form (p < 0.001). Four of the sustainability determinant constructs (responsive to community needs; coalitions, partnerships, and networks; organizational staff capability; and evaluation, feedback, and program outcomes) were also significantly associated with current SAMHSA funding status (p < 0.5 to 0.01). With the exception of organizational staff capability, all sustainability determinants were unrelated to program adaptation as predicted. CONCLUSIONS: The SMSS demonstrated good reliability and convergent and discriminant validity in assessing likelihood of sustainment of SAMHSA funded prevention programs and initiatives. The measure demonstrates potential in identifying predictors of program sustainment and as a tool for enhancing the likelihood of successful sustainment through ongoing evaluation and feedback.


Asunto(s)
Trastornos Relacionados con Sustancias , United States Substance Abuse and Mental Health Services Administration , Análisis Factorial , Humanos , Evaluación de Programas y Proyectos de Salud , Reproducibilidad de los Resultados , Trastornos Relacionados con Sustancias/prevención & control , Estados Unidos
13.
Psychol Trauma ; 12(S1): S279-S280, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32551754

RESUMEN

The ubiquitous exposure to COVID-19 argues for governments to use a trauma-informed response as a universal precaution, with the goal of promoting the recovery and resilience of their residents. How a system defines trauma will drive its administrative policies, research, and clinical services. The Substance Abuse and Mental Health Services Administration's Concept of Trauma and Guidance for a Trauma-Informed Approach offers governments a framework to define trauma and incorporate trauma-informed principles and tasks into their COVID-19 responses. (PsycInfo Database Record (c) 2020 APA, all rights reserved).


Asunto(s)
Infecciones por Coronavirus , Servicios de Salud Mental/normas , Pandemias , Neumonía Viral , Trauma Psicológico/diagnóstico , Trauma Psicológico/terapia , Adulto , COVID-19 , Humanos , Trauma Psicológico/etiología , Estados Unidos , United States Substance Abuse and Mental Health Services Administration
14.
Psychol Trauma ; 12(S1): S111-S112, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32551759

RESUMEN

The United States is facing both the coronavirus disease 2019 (COVID-19) pandemic and an ongoing epidemic of opioid overdose. Opioid use disorder is associated with other mental health problems, trauma, and social and health disparities. While the United States has acted to improve access to treatment for mental health and opioid use, research will be needed to understand the effectiveness of new policies in the context of COVID-19. (PsycInfo Database Record (c) 2020 APA, all rights reserved).


Asunto(s)
Infecciones por Coronavirus/psicología , Sobredosis de Droga/psicología , Epidemia de Opioides , Trastornos Relacionados con Opioides/tratamiento farmacológico , Trastornos Relacionados con Opioides/psicología , Pandemias , Neumonía Viral/psicología , Aislamiento Social , Adulto , COVID-19 , Humanos , Tratamiento de Sustitución de Opiáceos , Estados Unidos , United States Substance Abuse and Mental Health Services Administration
17.
Drug Alcohol Depend ; 210: 107960, 2020 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-32222560

RESUMEN

INTRODUCTION: There is concern that recreational marijuana legalization (RML) may lead to increased cannabis use disorder (CUD) among youth due to increased marijuana use. This study investigates whether adolescent substance use disorder treatment admissions for marijuana use increased in Colorado and Washington following RML. METHODS: Annual data on 2008-2017 treatment admissions for marijuana use from the SAMHSA TEDS-A dataset for adolescents age 12-17 were used to model state treatment admissions trends. Difference-in-differences models were used to investigate whether treatment admissions increased following RML in Colorado/Washington compared to non-RML states, after adjusting for socioeconomic characteristics and treatment availability. RESULTS: Over all states in the analysis, the rate of adolescent treatment admissions for marijuana use declined significantly over the study period (ß=-3.375, 95 % CI=-4.842, -1.907), with the mean rate falling nearly in half. The decline in admissions rate was greater in Colorado and Washington compared to non-RML states following RML, though this difference was not significant (ß=-7.671, 95 % CI=-38.798, 23.456). CONCLUSION: Adolescent treatment admissions for marijuana use did not increase in Colorado and Washington following RML. This may be because youth marijuana use did not increase, CUD did not increase (even if use did increase), or treatment seeking behaviors changed due to shifts in attitudes and perceptions of risk towards marijuana use.


Asunto(s)
Conducta del Adolescente , Legislación de Medicamentos/tendencias , Uso de la Marihuana/epidemiología , Uso de la Marihuana/tendencias , Admisión del Paciente/tendencias , United States Substance Abuse and Mental Health Services Administration/tendencias , Adolescente , Conducta del Adolescente/psicología , Cannabis , Niño , Colorado/epidemiología , Femenino , Hospitalización/tendencias , Humanos , Masculino , Abuso de Marihuana/epidemiología , Abuso de Marihuana/psicología , Abuso de Marihuana/terapia , Uso de la Marihuana/psicología , Estados Unidos/epidemiología , Washingtón/epidemiología
18.
Psychiatr Serv ; 71(5): 419-426, 2020 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-31996115

RESUMEN

OBJECTIVE: Although use of tele-mental health services is growing, there is limited research on how tele-mental health is deployed. This project aimed to describe how health centers use tele-mental health in conjunction with in-person care. METHODS: The 2018 Substance Abuse and Mental Health Services Administration Behavioral Health Treatment Services Locator database was used to identify community mental health centers and federally qualified health centers with telehealth capabilities. Maximum diversity sampling was applied to recruit health center leaders to participate in semistructured interviews. Inductive and deductive approaches were used to develop site summaries, and a matrix analysis was conducted to identify and refine themes. RESULTS: Twenty health centers in 14 states participated. All health centers used telepsychiatry for diagnostic assessment and medication prescribing, and 10 also offered therapy via telehealth. Some health centers used their own staff to provide tele-mental health services, whereas others contracted with external providers. In most health centers, tele-mental health was used as an adjunct to in-person care. In choosing between tele-mental health and in-person care, health centers often considered patient preference, patient acuity, and insurance status or payer. Although most health centers planned to continue offering tele-mental health, participants noted drawbacks, including less patient engagement, challenges sharing information within the care team, and greater inefficiency. CONCLUSIONS: Tele-mental health is generally used as an adjunct to in-person care. The results of this study can inform policy makers and clinicians regarding the various delivery models that incorporate tele-mental health.


Asunto(s)
Servicios de Salud Mental/organización & administración , Modelos Psicológicos , Centros de Tratamiento de Abuso de Sustancias , Telemedicina/organización & administración , Actitud del Personal de Salud , Humanos , Entrevistas como Asunto , Investigación Cualitativa , Estados Unidos , United States Substance Abuse and Mental Health Services Administration
19.
Pediatrics ; 144(2)2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31320466

RESUMEN

The developmental impact of opioid use during pregnancy is a subject of ongoing debate. Short-term neonatal outcomes, such as lower birth weight and neonatal abstinence syndrome, are the most well-recognized outcomes. However, knowledge gaps exist regarding longer-term neurocognitive and mental health outcomes. In this article, we summarize an expert panel discussion that was held in April 2018 by the Substance Abuse and Mental Health Services Administration and attended by national experts in the field of perinatal opioid exposure and its impact on child development. Despite the challenges with research in this area, there is emerging literature revealing an association between neonates exposed to opioids in utero and longer-term adverse neurocognitive, behavioral, and developmental outcomes. Although adverse sequalae may not be apparent in the neonatal period, they may become more salient as children develop and reach preschool and school age. Multiple variables (genetic, environmental, and biological) result in a highly complex picture. The next steps and strategies to support families impacted by opioid use disorder are explored. Model programs are also considered, including integrated care for the child and mother, parenting supports, and augmentations to home visiting.


Asunto(s)
Analgésicos Opioides/efectos adversos , Conducta Infantil/efectos de los fármacos , Desarrollo Infantil/efectos de los fármacos , Cognición/efectos de los fármacos , Trastornos Relacionados con Opioides/epidemiología , Efectos Tardíos de la Exposición Prenatal/epidemiología , Niño , Conducta Infantil/fisiología , Conducta Infantil/psicología , Desarrollo Infantil/fisiología , Cognición/fisiología , Congresos como Asunto , Femenino , Humanos , Masculino , Trastornos Relacionados con Opioides/diagnóstico , Trastornos Relacionados con Opioides/psicología , Embarazo , Efectos Tardíos de la Exposición Prenatal/diagnóstico , Efectos Tardíos de la Exposición Prenatal/psicología , Estados Unidos/epidemiología , United States Substance Abuse and Mental Health Services Administration/tendencias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...